Colorectal Cancer Clinical Trials in San Antonio

Showing 201-220 of 249 trials

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

NCT02033551

This is an extension study to evaluate the safety of Veliparib monotherapy or in combination with Carboplatin plus Paclitaxel or modified Folinic Acid/Fluorouracil/Irinotecan (FOLFIRI) in subjects with solid tumors.

Breast CancerOvarian CancerColon Cancer+3 more

AbbVie47 participantsStarted Dec 2013

Scottsdale, Arizona, United States • San Antonio, Texas, United States • Groningen, Netherlands +2 more locations

COMPLETEDPhase 3< 1 mile

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

NCT00002575

RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.

Colorectal Cancer

Alliance for Clinical Trials in Oncology810 participantsStarted Aug 1994

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +155 more locations

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

Colorectal Cancer Trials in Other Cities

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Vitamin D/Calcium Polyp Prevention Study

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Screening Tests in Detecting Colorectal Cancer

Gene Testing in Patients With Colon Cancer

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Other Conditions in San Antonio